Product Information

BONSITY 560 MCG/2.24 ML PEN is a generic product labeled by Alvogen Inc., priced at $474.1780 per ML under NDC 47781085289. Its NADAC has been published 68 times since Aug 6, 2025.

FDA first approved this application on Oct 4, 2019.

BONSITY 560 MCG/2.24 ML PEN

teriparatide
$474.1780per ML

Strength

250 ug/mL

Manufacturer

Alvogen Inc.

NDC

47781085289

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

TERIPARATIDE

Approval Type

New Drug (NDA)

FDA Application

NDA211939

FDA Approved

10/4/2019

On Market Since

6/6/2025

Pharmacological Classes

Parathyroid Hormone Analog
Parathyroid Hormone

Price Statistics

The NADAC for BONSITY 560 MCG/2.24 ML PEN has been published 68 times since Aug 6, 2025, and over the history we have for it it has declined 44.0%. The table below summarizes its recorded NADAC range and movement.

Current price$474.1780 per ML
All-time high$846.0749 (Oct 15, 2025)
All-time low$473.0713 (Oct 21, 2026)
52-week high$687.2508
52-week low$473.0713
Median price$595.5376
Average price$619.2321
Largest weekly change-20.7% (Oct 22, 2025)
Weeks tracked68
Tracking sinceAug 6, 2025

Price History

1W

+0.2%

1M

-1.2%

3M

-4.2%

6M

-11.4%

1Y

-31.0%

3Y

N/A

5Y

N/A

All

-44.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BONSITY 560 MCG/2.24 ML PEN?

The current National Average Drug Acquisition Cost (NADAC) for BONSITY 560 MCG/2.24 ML PEN, manufactured by Alvogen Inc., is $474.1780 per ML (NDC 47781085289), effective Nov 18, 2026.

How has the price of BONSITY 560 MCG/2.24 ML PEN changed over time?

Over the history we have for it, the NADAC for BONSITY 560 MCG/2.24 ML PEN has declined 44.0%. It has been tracked across 68 weekly CMS publications since Aug 6, 2025.

What are the highest and lowest recorded NADAC prices for BONSITY 560 MCG/2.24 ML PEN?

Since Aug 6, 2025, the NADAC for BONSITY 560 MCG/2.24 ML PEN has ranged from a low of $473.0713 (Oct 21, 2026) to a high of $846.0749 (Oct 15, 2025), with a median of $595.5376 per ML.

Are there cheaper alternatives to BONSITY 560 MCG/2.24 ML PEN?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BONSITY 560 MCG/2.24 ML PEN in a comparable dosage form, but none are currently priced below it.

Who manufactures BONSITY 560 MCG/2.24 ML PEN?

BONSITY 560 MCG/2.24 ML PEN (NDC 47781085289) is labeled by Alvogen Inc., and CMS classifies it as a generic product.